Status:
RECRUITING
Ongoing Dynamic Choice to Address HIV Treatment Interruption in Malawi
Lead Sponsor:
University of California, Los Angeles
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Partners in Hope, Inc.
Conditions:
HIV
Eligibility:
All Genders
15+ years
Phase:
NA
Brief Summary
Repeat and prolonged treatment interruption (TI) is common and the major threat to HIV epidemic control in eastern and southern Africa. The proposed project will test an innovative long-term dynamic c...
Detailed Description
Repeat and prolonged treatment interruption (TI) is common and the major threat to HIV epidemic control in eastern and southern Africa. The investigators define TI as \>28 days late for last ART appoi...
Eligibility Criteria
Inclusion
- 15 years of age or older
- living with HIV;
- initiated ART for the first time\>3-months ago (i.e., not a new initiate);
- non-pregnant;
- experienced Treatment Interuptions during their most recent ARTappointment (\>28 days late).
Exclusion
- pregnant women because the ART/antenatal care (ANC) programs are integrated and require additional considerations and linkages with antenatal services.
Key Trial Info
Start Date :
November 17 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2029
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT07220278
Start Date
November 17 2025
End Date
July 1 2029
Last Update
December 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Partners in Hope
Lilongwe, Malawi